Inhibition of HIV-1 Integrase gene expression by 10-23 DNAzyme

Journal of Biosciences

Volumn 37, Issue 3, 2012, Pages 493-502

  Singh, Nirpendra ^a   Ranjan, Atul ^b   Sur, Souvik ^b   Chandra, Ramesh ^a   Tandon, Vibha ^b  

^a UNIVERSITY OF DELHI   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

10 23 DNAzyme; HIV IN; Integrase EGFP expression inhibition

Indexed keywords

10 23 DNAZYME; DIN 116; DIN 152; DIN 54; INTEGRASE INHIBITOR; MESSENGER RNA; UNCLASSIFIED DRUG;

DNA; ENZYME; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS; INHIBITION;

COMPUTER PROGRAM; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; INTEGRASE GENE; PROTEIN EXPRESSION; RNA CLEAVAGE; VIRUS GENE;

BASE PAIRING; BASE SEQUENCE; DNA, CATALYTIC; DNA, SINGLE-STRANDED; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; HELA CELLS; HIV INTEGRASE; HUMANS; MODELS, MOLECULAR; NUCLEIC ACID CONFORMATION; RECOMBINANT FUSION PROTEINS; RNA CLEAVAGE; RNA, MESSENGER; SOFTWARE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84864339637     PISSN: 02505991     EISSN: 09737138     Source Type: Journal    
DOI: 10.1007/s12038-012-9216-4     Document Type: Conference Paper

References (41)

1. Achenbach JC, Chiuman W, Cruz RP and Li Y 2004 DNAzymes: from creation in vitro to application in vivo. Curr. Pharm. Biotechnol. 5 321-336
2. Beger C, Pierce LN, Kruger M, Marcusson EG, Robbins JM, Welcsh P, Welch PJ, Welte K, et al. 2001 Identification of Id4 as a regulator of BRCA1 expression by using a ribozymelibrary- based inverse genomics approach. Proc. Natl. Acad. Sci. USA 98 130-135
3. Breaker RR and Joyce GF 1994 ADNA enzyme that cleaves RNA. Chem. Biol. 1 223-229
4. Cairns MJ and Sun LQ 2004 Target-site selection for the 10-23 DNAzyme. Methods Mol. Biol. 252 267-277
5. Cao M, Ren H, Pan X, Pan W and Qi ZT 2004 Inhibition of EGFP expression by siRNA in EGFP-stably expressing Huh-7 cells. J. Virol. Methods 119 189-194
6. Chan CW and Khachigian LM 2009 DNAzymes and their therapeutic possibilities. Intern. Med. J. 39 249-251
7. Chandrasekhar K and Malathhi R 2003 Non-Watson Crick base pairs might stabilize RNA structural motifs in ribozymes - a comparative study of group-I intron structures. J. Biosci. 28 547-555
8. Dash BC and Banerjea AC 2004 Sequence-specific cleavage activities of DNA enzymes targeted against HIV-1 Gag and Nef regions. Oligonucleotides. 14 41-47
9. Evering TH and Markowitz M 2008 Raltegravir: an integrase inhibitor for HIV-1. Expert Opin. Investig. Drugs 17 413-422
10. Goila R and Banerjea AC 1998 Sequence specific cleavage of the HIV-1 coreceptor CCR5 gene by a hammer-head ribozyme and a DNA-enzyme: inhibition of the coreceptor function by DNAenzyme. FEBS Lett. 436 233-238
11. Goodchild J 2004 Oligonucleotide therapeutics: 25 years agrowing. Curr. Opin. Mol. Ther. 6 120-128
12. Gupta SP and Nagappa AN 2003 Design and development of integrase inhibitors as anti-HIV agents. Curr. Med. Chem. 10 1779-1794
13. Hou W, Ni Q, Wo J, Li M, Liu K, Chen L, Hu Z, Liu R and Hu M 2006 Inhibition of hepatitis B virus X gene expression by 10-23 DNAzymes. Antiviral Res. 72 190-196
14. Joyce GF 2001 RNA cleavage by the 10-23 DNA enzyme. Methods Enzymol. 341 503-517
15. Joyce GF 2004 Directed evolution of nucleic acid enzymes. Annu. Rev. Biochem. 73 791-836
16. Kurreck J, Wyszko E, Gillen C and Erdmann VA 2002 Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res. 30 1911-1918
17. Lu ZX, Ye M, Yan GR, Li Q, Tang M, Lee LM, Sun LQ and Cao Y 2005 Effect of EBVLMP1 targeted DNAzymes on cell proliferation and apoptosis. Cancer Gene Ther. 12 647-654
18. Mathews DH, Sabina J, Zuker M and Turner DH 1999 Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J. Mol. Biol. 288 911-940
19. Mitchell A, Dass CR, Sun LQ and Khachigian LM 2004 Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1. Nucleic Acids Res. 32 3065-3069
20. Nagy P, Arndt-Jovin DJ and Jovin TM 2003 Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells. Exp. Cell Res. 285 39-49
21. Ota N, Warashina M, Hirano K, Hatanaka K and Taira K 1998 Effects of helical structures formed by the binding arms of DNAzymes and their substrates on catalytic activity. Nucleic Acids Res. 26 3385-3391
22. Passman M, Weinberg M, Kew M and Arbuthnot P 2000 In situ demonstration of inhibitory effects of hammerhead ribozymes that are targeted to the hepatitis Bx sequence in cultured cells. Biochem. Biophys. Res. Commun. 268 728-733
23. Peracchi A 2004 Prospects for antiviral ribozymes and deoxyribozymes. Rev. Med. Virol. 14 47-64
24. Qin ZL, Zhao P, Zhang XL, Yu JG, Cao MM, Zhao LJ, Luan J and Qi ZT 2004 Silencing of SARS-CoV spike gene by small interfering RNA in HEK 293 T cells. Biochem. Biophys. Res. Commun. 324 1186-1193
25. Reeder J, Hochsmann M, Rehmsmeier M, Voss B and Giegerich R 2006 Beyond Mfold: recent advances in RNA bioinformatics. J. Biotechnol. 124 41-55
26. Roy S, Gupta N, Subramanian N, Mondal T, Banerjea AC and Das S 2008 Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viral RNA translation and replication. J. Gen. Virol. 89 1579-1586
27. Santoro SW and Joyce GF 1997 A general purpose RNA-cleaving DNA enzyme. Proc. Natl. Acad. Sci. USA 94 4262-4266
28. Saxena V and Dhole TN 2008 Preventive strategies for frequent outbreaks of Japanese encephalitis in Northern India. J. Biosci. 33 505-514
29. Schubert S and Kurreck J 2004 Ribozyme- and deoxyribozyme-strategies for medical applications. Curr. Drug Targets 5 667-681
30. Silverman SK 2004 Breaking up is easy to do (if you're a DNA enzyme that cleaves RNA). Chem. Biol. 11 7-8
31. Silverman SK 2005 In vitro selection, characterization, and application of deoxyribozymes that cleave RNA. Nucleic Acids Res. 33 6151-6163
32. Unwalla H and Banerjea AC 2001 Novel mono- and di-DNAenzymes targeted to cleave TAT or TAT-REVRNA inhibit HIV-1 gene expression. Antiviral Res. 51 127-139
33. Unwalla H, Chakraborti S, Sood V, Gupta N and Banerjea AC 2006 Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti- TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme. Antiviral Res. 72 134-144
34. Wang Y, Shen J, Shang X, Wang J, Li J, Yin J and Zou C 2011 Ezrin mRNA target site selection for DNAzymes using secondary structure and hybridization thermodynamics. Tumour Biol. 32 809-817
35. Warashina M, Kuwabara T, Nakamatsu Y and Taira K 1999 Extremely high and specific activity of DNA enzymes in cells with a Philadelphia chromosome. Chem. Biol. 6 237-250
36. Wu Y, Yu L, McMahon R, Rossi JJ, Forman SJ and Snyder DS 1999 Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes). Hum. Gene Ther. 10 2847-2857
37. Xie YY, Zhao XD, Jiang LP, Liu HL, Wang LJ, Fang P, Shen KL, Xie ZD, Wu YP and Yang XQ 2006 Inhibition of respiratory syncytial virus in cultured cells by nucleocapsid gene targeted deoxyribozyme (DNAzyme). Antiviral Res. 71 31-41
38. Zaborowska Z, Schubert S, Kurreck J and Erdmann VA 2005 Deletion analysis in the catalytic region of the 10-23 DNA enzyme. FEBS Lett. 579 554-558
39. Zhang X, Xu Y, Ling H and Hattori T 1999 Inhibition of infection of incoming HIV-1 virus by RNA-cleaving DNA enzyme. FEBS Lett. 458 151-156
40. Zuker M 2003 Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31 3406-3415
41. Zuker M and Stiegler P 1981 Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res. 9 133-148